COVID-19 , COVID-19 Related Compounds

Tamoxifen Citrate

  • Catalog Number : C5137
  • Number :
  • Size:
    Qty :
  • Price : 0 Inquiry
  • print

Introduction

Tamoxifen(ICI-46474) is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen.in vitro: 4-hydroxytamoxifen, the active metabolite of tamoxifen, estradiol and 13 estradiol metabolites were tested in concentrations ranging from 3.1 to 100 microM. Incubation time was 4 days and cell proliferation was measured by means of the ATP chemosensitivity test. 4-hydroxytamoxifen showed an IC50 value of 27 microM and 18 microM in MCF-7 and MDA-MB 231 cells, respectively. Tamoxifen failed to significantly inhibit T-47Daro spheroid cell proliferation over a 100-500 nM concentration range. in vivo: 30 μg tamoxifen/g body weight/day injected on three consecutive days is the optimal condition for the αMHC-MerCreMer system to induce recombination in the Rosa26-lacZ strain. MAPK signaling can be transiently activated in the brain, liver, or kidney of Braf(V637E)ER(T2) mice by a single injection of tamoxifen. Braf(V637E)ER(T2) mice provide a new versatile tool to study disease mechanisms elicited by MAPK activation, complementing gene knockout technology that is restricted to the analysis of loss-of-function phenotypes.

General Information

Cas No. 54965-24-1
Purity >98%
Molecular Weight 563.64
Formula C32H37NO8
Solubility DMSO : 250 mg/mL/ H2O:< 0.1 mg/mL
Storage instruction 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Recently Viewed Products

gotop link
Customized Product Contact Us
0